Patricia Balsas

650 total citations
14 papers, 449 citations indexed

About

Patricia Balsas is a scholar working on Molecular Biology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Patricia Balsas has authored 14 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Hematology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Patricia Balsas's work include Multiple Myeloma Research and Treatments (7 papers), Ubiquitin and proteasome pathways (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Patricia Balsas is often cited by papers focused on Multiple Myeloma Research and Treatments (7 papers), Ubiquitin and proteasome pathways (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). Patricia Balsas collaborates with scholars based in Spain, Singapore and Germany. Patricia Balsas's co-authors include Isabel Marzo, Javier Naval, Patricia Galán‐Malo, Alberto Anel, Elı́as Campo, Dolors Colomer, Gaël Roué, Virginia Amador, Patricia Pérez‐Galán and Maria Carmela Vegliante and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Patricia Balsas

14 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patricia Balsas Spain	10	290	153	133	101	81	14	449
Soraya Wuillème‐Toumi France	5	467 1.6×	151 1.0×	230 1.7×	75 0.7×	75 0.9×	6	553
Emmanuelle Ménoret France	10	444 1.5×	160 1.0×	194 1.5×	60 0.6×	119 1.5×	14	574
Justin Cidado United States	12	394 1.4×	187 1.2×	91 0.7×	64 0.6×	63 0.8×	36	561
Alexandra Moros Spain	6	230 0.8×	137 0.9×	52 0.4×	121 1.2×	33 0.4×	9	382
Alexander Hoellein Germany	11	313 1.1×	224 1.5×	55 0.4×	53 0.5×	66 0.8×	12	501
Nelida Sjak-Shie United States	12	367 1.3×	244 1.6×	295 2.2×	115 1.1×	88 1.1×	16	596
Luhong Sun United States	10	286 1.0×	213 1.4×	104 0.8×	207 2.0×	127 1.6×	19	564
Latha Sridharan United States	10	222 0.8×	367 2.4×	77 0.6×	107 1.1×	64 0.8×	11	656
Hans G. Drexler Germany	9	180 0.6×	154 1.0×	133 1.0×	150 1.5×	150 1.9×	11	485
Torsten Steinbrunn Germany	11	348 1.2×	98 0.6×	211 1.6×	47 0.5×	56 0.7×	21	460

Countries citing papers authored by Patricia Balsas

Since Specialization

Citations

This map shows the geographic impact of Patricia Balsas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patricia Balsas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patricia Balsas more than expected).

Fields of papers citing papers by Patricia Balsas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patricia Balsas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patricia Balsas. The network helps show where Patricia Balsas may publish in the future.

Co-authorship network of co-authors of Patricia Balsas

This figure shows the co-authorship network connecting the top 25 collaborators of Patricia Balsas. A scholar is included among the top collaborators of Patricia Balsas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patricia Balsas. Patricia Balsas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Clot, Guillem, Sı́lvia Beà, Eva Giné, et al.. (2024). SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma. Scientific Reports. 14(1). 7863–7863. 3 indexed citations

Balsas, Patricia, Ferran Nadeu, Álvaro Eguileor, et al.. (2022). Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma. Leukemia. 37(2). 408–421. 4 indexed citations

Balsas, Patricia, Luis Veloza, Guillem Clot, et al.. (2021). SOX11, CD70, and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma. Blood. 138(22). 2202–2215. 32 indexed citations

Balsas, Patricia, Vanina Rodríguez, Juan García Valero, et al.. (2017). Activity of the novel BCR kinase inhibitor IQS019 in preclinical models of B-cell non-Hodgkin lymphoma. Journal of Hematology & Oncology. 10(1). 80–80. 7 indexed citations

Balsas, Patricia, Jara Palomero, Álvaro Eguileor, et al.. (2017). SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma. Blood. 130(4). 501–513. 89 indexed citations

Matas‐Céspedes, Alba, Vanina Rodríguez, Susana G. Kalko, et al.. (2014). Disruption of Follicular Dendritic Cells–Follicular Lymphoma Cross-talk by the Pan-PI3K Inhibitor BKM120 (Buparlisib). Clinical Cancer Research. 20(13). 3458–3471. 21 indexed citations

Moros, Alexandra, Vanina Rodríguez, Ifigènia Saborit-Villarroya, et al.. (2014). Synergistic antitumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma. Leukemia. 28(10). 2049–2059. 77 indexed citations

Bellacasa, Raimon Puig de la, Gaël Roué, Patricia Balsas, et al.. (2014). 4-Amino-2-arylamino-6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7-(8H)-ones as BCR kinase inhibitors for B lymphoid malignancies. European Journal of Medicinal Chemistry. 86. 664–675. 23 indexed citations

Moros, Alexandra, Vanina Rodríguez, Ifigènia Saborit-Villarroya, et al.. (2014). Abstract 1691: Synergistic anti-tumor activity of lenalidomide with the BET bromodomain inhibitor CPI203 in bortezomib-resistant mantle cell lymphoma. Cancer Research. 74(19_Supplement). 1691–1691. 1 indexed citations

10.

Balsas, Patricia, Patricia Galán‐Malo, Isabel Marzo, & Javier Naval. (2011). Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy. Leukemia Research. 36(2). 212–218. 70 indexed citations

11.

Balsas, Patricia, et al.. (2009). Bim is the key mediator of glucocorticoid-induced apoptosis and of its potentiation by rapamycin in human myeloma cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1803(2). 311–322. 20 indexed citations

12.

Balsas, Patricia, et al.. (2008). Cooperation between Apo2L/TRAIL and bortezomib in multiple myeloma apoptosis. Biochemical Pharmacology. 77(5). 804–812. 49 indexed citations

13.

Gómez‐Benito, María José, Patricia Balsas, Xonia Carvajal‐Vergara, et al.. (2006). Mechanism of apoptosis induced by IFN-α in human myeloma cells: Role of Jak1 and Bim and potentiation by rapamycin. Cellular Signalling. 19(4). 844–854. 34 indexed citations

14.

Gómez‐Benito, María José, Patricia Balsas, Alberto Bosque, et al.. (2005). Apo2L/TRAIL is an indirect mediator of apoptosis induced by interferon‐α in human myeloma cells. FEBS Letters. 579(27). 6217–6222. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact